Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
5,634,598
-
Shares change
-
+162,429
-
Total reported value, excl. options
-
$18,198,000
-
Value change
-
+$467,508
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$3.23
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q3 2020
24 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q3 2020.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,634,598 shares
of 97,996,626 outstanding shares and own 5.7% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1,615,000 shares), FMR LLC (1,402,874 shares), Alyeska Investment Group, L.P. (752,646 shares), VIKING GLOBAL INVESTORS LP (587,444 shares), RENAISSANCE TECHNOLOGIES LLC (408,430 shares), VANGUARD GROUP INC (233,850 shares), TWO SIGMA ADVISERS, LP (168,250 shares), TWO SIGMA INVESTMENTS, LP (152,474 shares), ACADIAN ASSET MANAGEMENT LLC (83,052 shares), and GEODE CAPITAL MANAGEMENT, LLC (46,130 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.